These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 10414928

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Non-steroidal anti-inflammatory drugs activate NADPH oxidase in adipocytes and raise the H2O2 pool to prevent cAMP-stimulated protein kinase a activation and inhibit lipolysis.
    Vázquez-Meza H, de Piña MZ, Pardo JP, Riveros-Rosas H, Villalobos-Molina R, Piña E.
    BMC Biochem; 2013 May 30; 14():13. PubMed ID: 23718778
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of lipolytic and antilipolytic agents on glycerol and free fatty acid release from isolated adipocytes of normal and diabetic rats.
    Kamei I, Hotta N, Kakuta H, Kimura M, Fukasawa H, Koh N, Sakamoto N.
    Nagoya J Med Sci; 1989 Mar 30; 51(1-4):17-23. PubMed ID: 2549422
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes.
    Mei J, Holst LS, Landström TR, Holm C, Brindley D, Manganiello V, Degerman E.
    Diabetes; 2002 Mar 30; 51(3):631-7. PubMed ID: 11872660
    [Abstract] [Full Text] [Related]

  • 29. Effect of endothelin-1 on lipolysis in rat adipocytes.
    Juan CC, Chang LW, Huang SW, Chang CL, Lee CY, Chien Y, Hsu YP, Ho PH, Chen YC, Ho LT.
    Obesity (Silver Spring); 2006 Mar 30; 14(3):398-404. PubMed ID: 16648610
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML, Manganiello VC.
    Endocrinology; 1985 May 30; 116(5):2119-21. PubMed ID: 2985373
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
    Visentin V, Prévot D, Marti L, Carpéné C.
    Eur J Pharmacol; 2003 Apr 18; 466(3):235-43. PubMed ID: 12694806
    [Abstract] [Full Text] [Related]

  • 37. Wortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolin.
    Fain JN, Gokmen-Polar Y, Bahouth SW.
    Metabolism; 1997 Jan 18; 46(1):62-6. PubMed ID: 9005971
    [Abstract] [Full Text] [Related]

  • 38. Short-term fasting and lipolytic activity in rat adipocytes.
    Szkudelski T, Lisiecka M, Nowicka E, Kowalewska A, Nogowski L, Szkudelska K.
    Horm Metab Res; 2004 Oct 18; 36(10):667-73. PubMed ID: 15523590
    [Abstract] [Full Text] [Related]

  • 39. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
    Lönnroth P, Smith U.
    Biochem Biophys Res Commun; 1986 Dec 30; 141(3):1157-61. PubMed ID: 2434081
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.